Latest News

Monday, June 18, 2018

Michael Mazen Jafar is New Chief Marketing Officer at Evolus

Evolus, Inc. has expanded its management team with the appointment of Michael Mazen Jafar as Chief Marketing Officer. Mr. Jafar joins Evolus from Allergan where he most recently served as Vi…

Read the full story

Monday, June 18, 2018

Valeant: FDA Issues Complete Response Letter for Duobrii

Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc. has received a Complete Response Letter (CRL) from the US FDA regarding the company's New Drug Application …

Read the full story

Friday, June 15, 2018

New Data from DermTech Presented at International Investigational Dermatology Meeting

DermTech, Inc., has announced the publication of two clinical study abstracts at the 2018 International Investigational Dermatology meeting in Orlando, Fl. A real world clinical utility study, “…

Read the full story

Friday, June 15, 2018

Derm Brands Dove, Neutrogena, L'Oreal Among Top Skincare Social Influencers

Engagement Labs’ TotalSocial® ranking of the top personal care and beauty brands in the US based on social influence show several popular dermatology brands in the Top 10, including Dove, Ne…

Read the full story

Thursday, June 14, 2018

eRelevance Launches Suite of Services to Support Lead Conversion

eRelevance Corporation has launched a suite of tech-powered services to help SMBs grow more cost-effectively. The services drive more demand, lower advertising costs, and improve lead conver…

Read the full story

Wednesday, June 13, 2018

Xact Nabs Best of Hot Topics at ASAPS 2018

Cypris Medical, Inc.’s Xact technology took home the “Best of Hot Topics” award at the American Society for Aesthetic Plastic Surgery (ASAPS) meeting in New York. Xact technology …

Read the full story

Wednesday, June 13, 2018

Older Melanoma Patients May Have Better Response to Immune Checkpoint Blockade Therapy

Patient age correlates with response to immunotherapy in melanoma, and depleting regulatory T cells in young patients may have a therapeutic potential to enhance response in younger patients, accordin…

Read the full story

Tuesday, June 12, 2018

Restoration Robotics Launches Continuing Education Master Class for ARTAS System

Restoration Robotics, Inc. is launching a continuing education Master Class Series for its ARTAS® Robotic Hair Restoration System to train physicians on best practices and the most up-to-date…

Read the full story

Monday, June 11, 2018

ThermiVa: First-ever Data Show Vaginal Regeneration

Thermi’s ThermiVa® device has been shown to deliver significant improvements in common vaginal disorders and improve sexual satisfaction, according to a study published in Dermatologic …

Read the full story

Friday, June 08, 2018

PellePharm Presents New Data in BCC

PellePharm, a late clinical-stage biopharmaceutical company committed to targeting rare dermatologic conditions at their source, presented new data from its clinical and scientific research programs a…

Read the full story

Friday, June 08, 2018

Galderma Global Survey Assesses Burden of Rosacea

    Recently released findings from Galderma’s global survey on the true burden of rosacea suggest a need for dermatologists and doctors to proactively open a dialogue with patie…

Read the full story

Friday, June 08, 2018

InMode: New EmbraceRF Solution Introduces Subdermal Adipose Remodeling

Introducing the concept of Subdermal Adipose Remodeling, InMode Aesthetic Solutions is launching EmbraceRF to target the neck and face through a powerful combination of InMode’s&n…

Read the full story

Friday, June 08, 2018

Opdivo Data: Superior Recurrence-Free Survival Versus Ipilimumab

Updated results from the Phase 3 CheckMate -238 trial evaluating Opdivo (nivolumab, Bristol-Myers Squibb Company) versus Yervoy (ipilimumab, Bristol-Myers Squibb Company) …

Read the full story

Wednesday, June 06, 2018

White Coats, Scrubs Top Patient Preferences for Doctor’s Attire

What doctors wear matters…a lot, according to the largest-ever study of patient preferences for doctors’ attire. Just more than half of the 4,062 patients surveyed in the clinics …

Read the full story

Wednesday, June 06, 2018

Luma Therapeutics Launches Novel illuvinate Phototherapy System

Luma Therapeutics has launched illuvinate as an innovative and modern twist on the Goeckerman regimen. By combining a narrowband UVB LED light with patented hydrogels containing coal tar micro-globule…

Read the full story
Load More
 Stock Price  Change 
 AbbVie $97.82  -0.67% 
 Allergan $171.99  0.15% 
 Amgen $185.20  0.68% 
 Bayer AG $31.35  -0.56% 
 Celgene $78.97  1.60% 
 Cutera $42.83  -3.55% 
 GlaxoSmithKline $40.93  -0.84% 
 Johnson and Johnson $122.35  0.85% 
 Lily $86.37  0.30% 
 Nestle $73.86  -1.20% 
 Novartis $73.65  -0.60% 
 Pfizer $36.19  0.07% 
 Proctor and Gamble $76.21  0.49% 
 Taro $119.66  -0.20% 
 Unilever $53.93  -0.19% 
 Valeant $24.26  2.97%